Cargando…

Human papillomavirus infection and follow-up on positive results in 7222 female samples obtained from 2016 to 2019 in Hefei, China

BACKGROUND: Human papillomavirus (HPV) infection rates in women vary regionally. This study analyzed HPV infection in women of different age groups in Hefei, China, performed follow-up on positive cases, and discussed infection prognoses. METHODS: Samples (7,222) of exfoliated cervical cells were co...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Liduo, Yin, Liping, Dai, Yaqian, Peng, Yuanjing, Xu, Yuanhong, Hu, Huaqing, Qiao, Jinping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583622/
https://www.ncbi.nlm.nih.gov/pubmed/33150081
http://dx.doi.org/10.7717/peerj.10179
_version_ 1783599429338529792
author Peng, Liduo
Yin, Liping
Dai, Yaqian
Peng, Yuanjing
Xu, Yuanhong
Hu, Huaqing
Qiao, Jinping
author_facet Peng, Liduo
Yin, Liping
Dai, Yaqian
Peng, Yuanjing
Xu, Yuanhong
Hu, Huaqing
Qiao, Jinping
author_sort Peng, Liduo
collection PubMed
description BACKGROUND: Human papillomavirus (HPV) infection rates in women vary regionally. This study analyzed HPV infection in women of different age groups in Hefei, China, performed follow-up on positive cases, and discussed infection prognoses. METHODS: Samples (7,222) of exfoliated cervical cells were collected in Hefei and tested with an HPV assay kit against 27 HPV genotypes. Statistical software was used to analyze the data. RESULTS: The total positive rate of infection was 17.13% (1,068 women), and the 51–60-year age group had the highest HPV infection rate (19.82%). There were statistically significant differences between rates in the 21–30 and 31–40 (P = 0.002), 21–30 and 41–50 (P = 0.0003), 21–30 and 51–60 (P = 0.00003), and 51–60 and >60 age groups (P = 0.046). High-risk infection (15.67%) and single infection (13.01%) were the main types of HPV infection. The dominant genotypes of high-risk infection were HPV 52 (2.42%), HPV 16 (2.01%), HPV 53 (1.43%), HPV 58 (1.32%) and HPV 66 (1.01%). We conducted follow-up on cases in 69 of 94 women who had a history of 1–4 years of positive infection, and in 18 (seven treated, 11 untreated) patients, infection status turned negative (26.09%). Seventeen of the fifty-one women whose infections did not turn negative received treatment. Persistent infection was predominantly observed in high-risk genotypes (56 of 69). CONCLUSIONS: The results recommend that women in Hefei improve health awareness and receive a 9-valent vaccine. Additionally, women with persistent infections should consult a gynecologist to prevent cervical lesions.
format Online
Article
Text
id pubmed-7583622
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-75836222020-11-03 Human papillomavirus infection and follow-up on positive results in 7222 female samples obtained from 2016 to 2019 in Hefei, China Peng, Liduo Yin, Liping Dai, Yaqian Peng, Yuanjing Xu, Yuanhong Hu, Huaqing Qiao, Jinping PeerJ Virology BACKGROUND: Human papillomavirus (HPV) infection rates in women vary regionally. This study analyzed HPV infection in women of different age groups in Hefei, China, performed follow-up on positive cases, and discussed infection prognoses. METHODS: Samples (7,222) of exfoliated cervical cells were collected in Hefei and tested with an HPV assay kit against 27 HPV genotypes. Statistical software was used to analyze the data. RESULTS: The total positive rate of infection was 17.13% (1,068 women), and the 51–60-year age group had the highest HPV infection rate (19.82%). There were statistically significant differences between rates in the 21–30 and 31–40 (P = 0.002), 21–30 and 41–50 (P = 0.0003), 21–30 and 51–60 (P = 0.00003), and 51–60 and >60 age groups (P = 0.046). High-risk infection (15.67%) and single infection (13.01%) were the main types of HPV infection. The dominant genotypes of high-risk infection were HPV 52 (2.42%), HPV 16 (2.01%), HPV 53 (1.43%), HPV 58 (1.32%) and HPV 66 (1.01%). We conducted follow-up on cases in 69 of 94 women who had a history of 1–4 years of positive infection, and in 18 (seven treated, 11 untreated) patients, infection status turned negative (26.09%). Seventeen of the fifty-one women whose infections did not turn negative received treatment. Persistent infection was predominantly observed in high-risk genotypes (56 of 69). CONCLUSIONS: The results recommend that women in Hefei improve health awareness and receive a 9-valent vaccine. Additionally, women with persistent infections should consult a gynecologist to prevent cervical lesions. PeerJ Inc. 2020-10-20 /pmc/articles/PMC7583622/ /pubmed/33150081 http://dx.doi.org/10.7717/peerj.10179 Text en ©2020 Peng et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Virology
Peng, Liduo
Yin, Liping
Dai, Yaqian
Peng, Yuanjing
Xu, Yuanhong
Hu, Huaqing
Qiao, Jinping
Human papillomavirus infection and follow-up on positive results in 7222 female samples obtained from 2016 to 2019 in Hefei, China
title Human papillomavirus infection and follow-up on positive results in 7222 female samples obtained from 2016 to 2019 in Hefei, China
title_full Human papillomavirus infection and follow-up on positive results in 7222 female samples obtained from 2016 to 2019 in Hefei, China
title_fullStr Human papillomavirus infection and follow-up on positive results in 7222 female samples obtained from 2016 to 2019 in Hefei, China
title_full_unstemmed Human papillomavirus infection and follow-up on positive results in 7222 female samples obtained from 2016 to 2019 in Hefei, China
title_short Human papillomavirus infection and follow-up on positive results in 7222 female samples obtained from 2016 to 2019 in Hefei, China
title_sort human papillomavirus infection and follow-up on positive results in 7222 female samples obtained from 2016 to 2019 in hefei, china
topic Virology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583622/
https://www.ncbi.nlm.nih.gov/pubmed/33150081
http://dx.doi.org/10.7717/peerj.10179
work_keys_str_mv AT pengliduo humanpapillomavirusinfectionandfollowuponpositiveresultsin7222femalesamplesobtainedfrom2016to2019inhefeichina
AT yinliping humanpapillomavirusinfectionandfollowuponpositiveresultsin7222femalesamplesobtainedfrom2016to2019inhefeichina
AT daiyaqian humanpapillomavirusinfectionandfollowuponpositiveresultsin7222femalesamplesobtainedfrom2016to2019inhefeichina
AT pengyuanjing humanpapillomavirusinfectionandfollowuponpositiveresultsin7222femalesamplesobtainedfrom2016to2019inhefeichina
AT xuyuanhong humanpapillomavirusinfectionandfollowuponpositiveresultsin7222femalesamplesobtainedfrom2016to2019inhefeichina
AT huhuaqing humanpapillomavirusinfectionandfollowuponpositiveresultsin7222femalesamplesobtainedfrom2016to2019inhefeichina
AT qiaojinping humanpapillomavirusinfectionandfollowuponpositiveresultsin7222femalesamplesobtainedfrom2016to2019inhefeichina